Oppenheimer Adjusts Price Target on Regeneron Pharmaceuticals to $1,175 From $1,125
MT NewswiresApr 26 08:24 ET
Wells Fargo Reaffirms Their Buy Rating on Regeneron (REGN)
TipRanksApr 25 05:44 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 24 13:37 ET
TD Cowen Adjusts Regeneron Pharmaceuticals' Price Target to $1,030 From $1,020, Keeps Buy Rating
MT NewswiresApr 24 06:46 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 17 09:23 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 15 14:27 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 12 08:02 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 9 09:40 ET
Regeneron (REGN) Receives a Buy From RBC Capital
TipRanksApr 9 06:45 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaApr 3 09:38 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaMar 26 09:34 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaMar 13 07:59 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaMar 11 16:43 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaFeb 27 09:55 ET
RBC Raises Price Target on Regeneron Pharmaceuticals to $1,184 From $1,096, Keeps Outperform Rating
MT NewswiresFeb 27 07:37 ET
Goldman Sachs Cuts Alnylam Pharma Stock to Neutral Following HELIOS-B Study Update
InvestingFeb 16 08:42 ET
Deutsche Bank Adjusts Price Target on Regeneron Pharmaceuticals to $880 From $870, Maintains Hold Rating
MT NewswiresFeb 6 09:59 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaFeb 6 09:36 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaFeb 5 09:13 ET
Regeneron Pharmaceuticals Analyst Ratings
BenzingaJan 29 12:43 ET
No Data
No Data